A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome.
Open accessThe DOI matches its OpenAlex record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
and BBR in the managing of MetS; nevertheless more investigations, especially reliable clinical trials, need to be accomplished to evaluate their effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937 · cited 1×
“Metabolic syndrome (MetS), also described as ‘insulin resistance syndrome’ (1), ‘syndrome X’ (2), ‘hypertriglyceridemic waist’ (3) and ‘the deadly quartet’ (4) characterized by a cluster of metabolic abnormalities including hypertension, obesity, insulin resistance and dyslipidemia, is a well-known risk factor for typ…”
BackgroundGrundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573
Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.09.049 · Cited by 458 · cited 1×
“hypertension with no serious side effect (70).”
Cardiovascular effects of berberine in patients with severe congestive heart failure
Marin ‐ NETO, J. A., Maciel, B. C., Secches, A. L., & Gallo, L. (1988) · Clinical Cardiology · doi:10.1002/clc.4960110411 · Cited by 128 · cited 1×
“Examination of hemodynamic parameters in humans revealed similar results with increased cardiac index and left ventricular ejection fraction, decreased systemic and pulmonary vascular resistance and left ventricular end-diastolic pressures (61).”
ResultAntioxidant and cytoprotective compounds from Berberis vulgaris (barberry)
Tomosaka, H., Chin, Y., Salim, A. A., Keller, W. J., Chai, H., & Kinghorn, A. D. (2008) · Phytotherapy Research · doi:10.1002/ptr.2443 · Cited by 97 · cited 1×
“Different parts of this plant including fruits, leaves and roots, have been used in traditional medicine for a long time (22).”
BackgroundZhou, Y., Cao, S., Wang, Y., Xu, P., Yan, J., Bin, W., Qiu, F., & Kang, N. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.11.010 · Cited by 81
Di Pierro, F., Bellone, I., Rapacioli, G., & Putignano, P. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s78877 · Cited by 48
Pycnogenol® in Metabolic Syndrome and Related Disorders
Gulati, O. P. (2015) · Phytotherapy Research · doi:10.1002/ptr.5341 · Cited by 39 · cited 1×
“Dyslipidemia is chiefly known as a triad of low HDL-C together with increases in triglycerides (TGs) and LDL (low-density lipoprotein) (37).”
Background
Cited by
Quercetin and metabolic syndrome: A review
Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 386
Self-citationBerberine and barberry (Berberis vulgaris): A clinical review
Imenshahidi, M., & Hosseinzadeh, H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6252 · Cited by 368
Self-citationBerberine as a potential autophagy modulator
Mohammadinejad, R., Ahmadi, Z., Tavakol, S., & Ashrafizadeh, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28325 · Cited by 132
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
“Berberine (BBR) is a quaternary ammonium salt from the group of bioactive isoquinoline alkaloids (Imenshahidi and Hosseinzadeh, 2016), which is the major active component of traditional Chinese herb Coptis chinensis (Tabeshpour et al., 2017).”
BackgroundRameshrad, M., Razavi, B. M., Ferns, G. A. A., & Hosseinzadeh, H. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00238-7 · Cited by 34
Self-citation
Metadata
- Authors
- Tabeshpour, J., Imenshahidi, M., & Hosseinzadeh, H.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2017-05-01
- Volume
- 20
- Issue
- 5
- Pages
- 557-568
- OpenAlex
- W2698548050
- Cited by
- 115
- References
- 12
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.